The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Travel, Accommodations, Expenses - Bayer
Maximal androgen blockade therapy (MAB) for prostate cancer (PC) and risk of bone fractures: A systematic literature review and meta-analysis.
 
Fabio Turco
No Relationships to Disclose
 
Isabella Saporita
No Relationships to Disclose
 
Mariangela Calabrese
No Relationships to Disclose
 
Federica Maria Carfi
No Relationships to Disclose
 
Andrea Mogavero
No Relationships to Disclose
 
Giorgio Treglia
No Relationships to Disclose
 
Silke Gillessen
Consulting or Advisory Role - Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); BMS (Inst); Boehringer Ingelheim (Inst); Daiichi Sankyo Europe GmbH (Inst); InnoMedica (Inst); Ipsen (Inst); Macrogenics (Inst); MSD Oncology (Inst); Myriad Genetics (Inst); Orion (Inst); PeerVoice (Inst); WebMD/Medscape (Inst)
Speakers' Bureau - AdMeTech Foundation (Inst); ASCO GU (Inst); EPG Health (Inst); ESMO (Inst); German-speaking European School of Oncology (DESO); Intellisphere (Inst); Meister ConCept GmbH (Inst); Schweizerische Gesellschaft für Medizinische Onkologie; Silvia Grasso Consulting (Inst); Swiss Group for Clinical Cancer Research (SAKK); Swiss Group for Clinical Cancer Research (SAKK) (Inst)
Patents, Royalties, Other Intellectual Property - Method for biomarker (WO 3752009138392 A1)
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Gilead Sciences; Intellisphere
Other Relationship - Cold Spring Harbor Laboratory (Inst); ProteoMediX
 
Massimo Di Maio
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Boehringer Ingelheim; Eisai; Janssen; Merck Serono; MSD Oncology; Novartis; Pfizer; Roche; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca; Eisai; Janssen; Merck Serono; MSD Oncology; Novartis; Pfizer; Roche; Takeda
Research Funding - GlaxoSmithKline (Inst); Tesaro (Inst)
 
Marcello Tucci
No Relationships to Disclose
 
Consuelo ButtIgliero
No Relationships to Disclose
 
Ursula Vogl
Consulting or Advisory Role - Astellas Oncology (Inst); Bayer (Inst); BMS GmbH & Co. KG (Inst); Ipsen (Inst); Janssen (Inst); Merck (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Sandoz (Inst)
Expert Testimony - Merck (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; Merck